NOVAVAX INC (NVAX) › Operating IncomeNOVAVAX INC (NVAX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$37.38M2010: -$38.49M2011: -$21.58M2012: -$29.66M2013: -$52.43M2014: -$83.69M2015: -$157.24M2016: -$269.11M2017: -$171.71M2018: -$173.92M2019: -$120.58M2020: -$416.72M2021: -$1.69B2022: -$644.74M2023: -$566.51M2024: -$248.93M2025: $452.80M$452.80M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$452.80M+281.9%2024-$248.93M+56.1%2023-$566.51M+12.1%2022-$644.74M+61.8%2021-$1.69B-304.7%2020-$416.72M-245.6%2019-$120.58M+30.7%2018-$173.92M-1.3%2017-$171.71M+36.2%2016-$269.11M-71.2%2015-$157.24M-87.9%2014-$83.69M-59.6%2013-$52.43M-76.8%2012-$29.66M-37.5%2011-$21.58M+43.9%2010-$38.49M-3.0%2009-$37.38M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share